211 related articles for article (PubMed ID: 2476621)
1. Thiorphan, an inhibitor of endopeptidase 24.11, potentiates the natriuretic activity of atrial natriuretic peptide.
Trapani AJ; Smits GJ; McGraw DE; Spear KL; Koepke JP; Olins GM; Blaine EH
J Cardiovasc Pharmacol; 1989 Sep; 14(3):419-24. PubMed ID: 2476621
[TBL] [Abstract][Full Text] [Related]
2. Interaction of ANP and bradykinin during endopeptidase 24.11 inhibition: renal effects.
Smits GJ; McGraw DE; Trapani AJ
Am J Physiol; 1990 May; 258(5 Pt 2):F1417-24. PubMed ID: 2140018
[TBL] [Abstract][Full Text] [Related]
3. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.
Wegner M; Ganten D; Stasch JP
Hypertens Res; 1996 Dec; 19(4):229-38. PubMed ID: 8986453
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic profile of CGS 24128, a potent, long-acting inhibitor of neutral endopeptidase 24.11.
Trapani AJ; Beil ME; Coté DT; de Lombaert S; Erion MD; Gerlock TE; Ghai RD; Hopkins MF; Peppard JV; Webb RL
J Cardiovasc Pharmacol; 1994 Mar; 23(3):358-64. PubMed ID: 7515977
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity.
Capasso G; Unwin R; Ciani F; Rizzo A; Russo F; Pica A; De Santo NG
Nephron; 2000 Nov; 86(3):298-305. PubMed ID: 11096287
[TBL] [Abstract][Full Text] [Related]
6. Interaction of non-guanylate cyclase-linked atriopeptin receptor ligand and endopeptidase inhibitor in conscious rats.
Koepke JP; Tyler LD; Trapani AJ; Bovy PR; Spear KL; Olins GM; Blaine EH
J Pharmacol Exp Ther; 1989 Apr; 249(1):172-6. PubMed ID: 2565386
[TBL] [Abstract][Full Text] [Related]
7. Effects of the neutral endopeptidase inhibitor thiorphan on cardiovascular and renal function in cirrhotic rats.
Park KS; Li Y; Zhang Y; Gerbes AL; Liu H; Swain MG; Lee SS
Br J Pharmacol; 2003 May; 139(1):81-8. PubMed ID: 12746226
[TBL] [Abstract][Full Text] [Related]
8. Role of endogenous atrial natriuretic peptide in regulating sodium excretion in spontaneously hypertensive rats. Effects of neutral endopeptidase inhibition.
Hirata Y; Matsuoka H; Hayakawa H; Sugimoto T; Suzuki E; Sugimoto T; Kangawa K; Matsuo H
Hypertension; 1991 Jun; 17(6 Pt 2):1025-32. PubMed ID: 1828456
[TBL] [Abstract][Full Text] [Related]
9. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
[TBL] [Abstract][Full Text] [Related]
10. Interaction of a neutral endopeptidase inhibitor with an ANP-C receptor ligand in anesthetized dogs.
Wegner M; Stasch JP; Hirth-Dietrich C; Dressel J; Voges KP; Kazda S
Clin Exp Hypertens; 1995 Aug; 17(6):861-76. PubMed ID: 7581258
[TBL] [Abstract][Full Text] [Related]
11. Degradation of atrial natriuretic peptide: pharmacologic effects of protease EC 24.11 inhibition.
Webb RL; Yasay GD; McMartin C; McNeal RB; Zimmerman MB
J Cardiovasc Pharmacol; 1989 Aug; 14(2):285-93. PubMed ID: 2476603
[TBL] [Abstract][Full Text] [Related]
12. Enkephalinase inhibition increases plasma atrial natriuretic peptide levels, glomerular filtration rate, and urinary sodium excretion in rats with reduced renal mass.
Lafferty HM; Gunning M; Silva P; Zimmerman MB; Brenner BM; Anderson S
Circ Res; 1989 Sep; 65(3):640-6. PubMed ID: 2548762
[TBL] [Abstract][Full Text] [Related]
13. Effect of endopeptidase 24.11 inhibition in conscious cardiomyopathic hamsters.
Smits GJ; McGraw DE; Trapani AJ; Blaine EB
J Pharmacol Exp Ther; 1990 Jul; 254(1):176-9. PubMed ID: 2142219
[TBL] [Abstract][Full Text] [Related]
14. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
[TBL] [Abstract][Full Text] [Related]
15. Captopril attenuates diuretic and natriuretic actions of furosemide but not atrial natriuretic peptide.
Di Nicolantonio R; Morgan TO
Clin Exp Hypertens A; 1987; 9(1):19-32. PubMed ID: 2953509
[TBL] [Abstract][Full Text] [Related]
16. Specific inhibitors of endopeptidase 24.11 inhibit the metabolism of atrial natriuretic peptides in vitro and in vivo.
Olins GM; Krieter PA; Trapani AJ; Spear KL; Bovy PR
Mol Cell Endocrinol; 1989 Feb; 61(2):201-8. PubMed ID: 2521834
[TBL] [Abstract][Full Text] [Related]
17. Atriopeptin regulation and renal function in conscious spontaneously hypertensive rats.
Koepke JP; Tyler LD; Mehta PP; Olins GM; Trapani AJ; Hartupee DA; Bovy PR; Spear KL; Blaine EH
Am J Hypertens; 1990 Aug; 3(8 Pt 1):622-7. PubMed ID: 2171564
[TBL] [Abstract][Full Text] [Related]
18. Thiorphan-induced natriuresis in volume-expanded rats: roles of endogenous atrial natriuretic factor and kinins.
Bralet J; Mossiat C; Gros C; Schwartz JC
J Pharmacol Exp Ther; 1991 Sep; 258(3):807-11. PubMed ID: 1653839
[TBL] [Abstract][Full Text] [Related]
19. Renal response of anesthetized rats to low-dose infusion of atrial natriuretic peptide.
Soejima H; Grekin RJ; Briggs JP; Schnermann J
Am J Physiol; 1988 Sep; 255(3 Pt 2):R449-55. PubMed ID: 2970807
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors.
Hirata Y; Suzuki Y; Suzuki E; Hayakawa H; Kimura K; Goto A; Omata M; Minamino N; Kangawa K; Matsuo H
J Hypertens; 1994 Apr; 12(4):367-74. PubMed ID: 8064160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
